Featured Publications
Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An Expert Clinical Consensus from the National Lipid Association
Daniel E Soffer, Nicholas A Marston, Kevin C Maki, Terry A Jacobson, Jessica M Peña, George Thanassoulis, Seth S Martin, Carol F Kirkpatrick, Salim S Virani, Dave L Dixon, Christie M Ballantyne, Alan T Remaley
This National Lipid Association (NLA) Expert Clinical Consensus provides an overview of the physiologic and clinical considerations regarding the role of apolipoprotein B (apoB) measurement to guide clinical care based on the available scientific evidence and expert opinion.
Obesity, dyslipidemia, and cardiovascular disease: A joint expert review
Harold Edward Bays, Carol F Kirkpatrick, Kevin C Maki, Peter P Toth, Ryan T Morgan, Justin Tondt, Sandra Michelle Christensen, Dave L Dixon, Terry A Jacobson
This joint expert review by the Obesity Medicine Association (OMA) and National Lipid Association (NLA) provides clinicians an overview of the pathophysiologic and clinical considerations regarding obesity, dyslipidemia, and cardiovascular disease (CVD) risk.
W-3 polyunsaturated fatty acid status testing in humans: A narrative review of commercially available options
Mary R Dicklin Joshua C Anthony, Barbara L Winters, Kevin C Maki
There is an increasing body of evidence supporting a link between low intakes of ω-3 long-chain polyunsaturated fatty acids (LCPUFA) and numerous diseases and health conditions. However, few people are achieving the levels of fish/seafood or eicosapentaenoic acid and docosahexaenoic acid intake recommended in national and international guidelines. Knowledge of a person's ω-3 LCPUFA status will benefit the interpretation of research results and could be expected to lead to an increased effort to increase intake.
Nutrition interventions for adults with dyslipidemia: A clinical perspective from the National Lipid Association
Carol F Kirkpatrick, Geeta Sikand, Kristina S Petersen, Cheryl A M Anderson, Karen E Aspry, Julie P Bolick, Penny M Kris-Etherton
Lifestyle habits can have a profound impact on atherosclerotic cardiovascular disease (ASCVD) risk. The National Lipid Association previously published recommendations for lifestyle therapies to manage dyslipidemia.
Comparison of the effects of a phospholipid-enhanced fish oil versus krill oil product on plasma levels of eicosapentaenoic and docosahexaenoic acids after acute administration
Liana L Guarneiri, Meredith L Wilcox, Kevin C Maki
This randomized, double-blind, crossover study evaluated the bioavailability of eicosapentaenoic and docosahexaenoic acids (EPA+DHA) in a phospholipid-enhanced fish oil (PEFO) product versus a krill oil (KO) product (337 versus 206 mg EPA+DHA/1 g capsule) in healthy adults (N = 24). The aim of this study was to assess the plasma levels of EPA, DHA, and EPA+DHA following a single capsule of PEFO versus KO products in healthy adult men and women.
Red meat consumption and risk factors for type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials
Lisa M Sanders, Meredith L Wilcox, Kevin C. Maki
Results from observational studies suggest an association of red meat intake with risk of type 2 diabetes mellitus (T2D). However, results from randomized controlled trials (RCTs) have not clearly supported a mechanistic link between red meat intake and T2D risk factors. Therefore, a systematic review and meta-analysis were conducted on RCTs evaluating the effects of diets containing red meat (beef, pork, lamb, etc.), compared to diets with lower or no red meat, on markers of glucose homeostasis in adults.
How low should one go in reducing carbohydrate?
Carol F Kirkpatrick, Anandita Agarwala, Kevin C Maki
Declaration of Competing Interest Disclosures for KCM during the prior 24 months include research funding and/or consulting fees from the following: 89bio, Inc., Acasti Pharma Inc., Beren Therapeutics, Bragg Live Products, Cargill, Eli Lilly and Company, General Mills, Greenyn Biotechnology, Hass Avocado Board, Indiana University Foundation, Matinas BioPharma, National Cattlemen's Beef Association, National Dairy Council, Naturmega, New Amsterdam Pharma, Pepsico, and Pharmavite. CFK and AA have nothing to disclose.
Keto is trending: implications for body weight and lipid management
Carol F Kirkpatrick, Kaye-Eileen Willard, Kevin C Maki
Very-low-carbohydrate (VLC) and ketogenic diets (KDs) have been used for weight loss and more recently in patients with insulin resistance and type 2 diabetes. The impact of VLC and KDs on lipids/lipoproteins is a concern. The purpose of this review is to discuss the impact of KDs on body weight and lipids/lipoproteins.
Investigation of the Influence of a Bitter Melon Product on Indicators of Cardiometabolic Health in Adults with Prediabetes
Liana L Guarneiri, Meredith L Wilcox, Chen-Meng Kuan, Kevin C Maki
The purpose of this study was to assess the impact of bitter melon extract supplementation on glycemia in individuals with prediabetes.
Beef consumption and cardiovascular disease risk factors: A systematic review and meta-analysis of randomized controlled trials
Lisa M Sanders, Meredith L. Wilcox, Kevin C. Maki
Results from observational studies suggest an association of red meat intake with risk of type 2 diabetes mellitus (T2D). However, results from randomized controlled trials (RCTs) have not clearly supported a mechanistic link between red meat intake and T2D risk factors. Therefore, a systematic review and meta-analysis were conducted on RCTs evaluating the effects of diets containing red meat (beef, pork, lamb, etc.), compared to diets with lower or no red meat, on markers of glucose homeostasis in adults.